MicrobiologybioRxivPreprint
Mucin anchoring of SARS-CoV-2 neutralizing nanobinders increases intranasal antiviral efficacy
Joelton Rocha Gomes, Juliette Jacquelin, Amélie Donchet…·Nicolas Meunier
This study shows that anchoring a SARS-CoV-2 neutralizing nanobinder to mucin increases its residence time in the nasal cavity, enhancing antiviral efficacy in hamsters.
DOI 10.1101/2025.04.10.648177